Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

BACKGROUND: Acute myeloid leukemia (AML) stem cells (LSCs) are capable of surviving current standard chemotherapy and are the likely source of deadly, relapsed disease. While stem cell transplant serves as proof-of-principle that AML LSCs can be eliminated by the immune system, the translation of ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbrich, Shelley, Baran, Natalia, Cai, Tianyu, Weng, Connie, Aitken, Marisa J L, Post, Sean M, Henderson, Jared, Shi, Chunhua, Havranek, Ondrej, Richard-Carpentier, Guillame, Sauvageau, Guy, Baggerly, Keith, Al-Atrash, Gheath, Davis, R Eric, Daver, Naval, Zha, Dongxing, Konopleva, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323398/
https://www.ncbi.nlm.nih.gov/pubmed/34326171
http://dx.doi.org/10.1136/jitc-2021-002968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323398/
https://www.ncbi.nlm.nih.gov/pubmed/34326171
http://dx.doi.org/10.1136/jitc-2021-002968

Ejemplares similares